rs4126690

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001205293.3(CACNA1E):​c.512+3897G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.265 in 152,036 control chromosomes in the GnomAD database, including 5,951 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.26 ( 5951 hom., cov: 32)

Consequence

CACNA1E
NM_001205293.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.582

Publications

5 publications found
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 69
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.391 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ENM_001205293.3 linkc.512+3897G>T intron_variant Intron 3 of 47 ENST00000367573.7 NP_001192222.1 Q15878-1Q59FG1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1EENST00000367573.7 linkc.512+3897G>T intron_variant Intron 3 of 47 1 NM_001205293.3 ENSP00000356545.2 Q15878-1
CACNA1EENST00000360108.7 linkc.512+3897G>T intron_variant Intron 3 of 46 5 ENSP00000353222.3 F8W9Z1
CACNA1EENST00000367570.6 linkc.512+3897G>T intron_variant Intron 3 of 46 1 ENSP00000356542.1 Q15878-3
CACNA1EENST00000621791.4 linkc.512+3897G>T intron_variant Intron 3 of 45 1 ENSP00000481619.1 Q15878-2
CACNA1EENST00000524607.6 linkc.947+3897G>T intron_variant Intron 5 of 11 5 ENSP00000432038.2 E9PIE8

Frequencies

GnomAD3 genomes
AF:
0.264
AC:
40169
AN:
151918
Hom.:
5931
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.384
Gnomad AMI
AF:
0.249
Gnomad AMR
AF:
0.244
Gnomad ASJ
AF:
0.170
Gnomad EAS
AF:
0.144
Gnomad SAS
AF:
0.407
Gnomad FIN
AF:
0.217
Gnomad MID
AF:
0.283
Gnomad NFE
AF:
0.208
Gnomad OTH
AF:
0.260
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.265
AC:
40220
AN:
152036
Hom.:
5951
Cov.:
32
AF XY:
0.268
AC XY:
19894
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.384
AC:
15920
AN:
41424
American (AMR)
AF:
0.244
AC:
3727
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.170
AC:
590
AN:
3466
East Asian (EAS)
AF:
0.144
AC:
746
AN:
5176
South Asian (SAS)
AF:
0.406
AC:
1955
AN:
4818
European-Finnish (FIN)
AF:
0.217
AC:
2295
AN:
10562
Middle Eastern (MID)
AF:
0.284
AC:
83
AN:
292
European-Non Finnish (NFE)
AF:
0.208
AC:
14130
AN:
67994
Other (OTH)
AF:
0.260
AC:
547
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1458
2917
4375
5834
7292
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
406
812
1218
1624
2030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.227
Hom.:
2542
Bravo
AF:
0.268
Asia WGS
AF:
0.265
AC:
922
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
1.7
DANN
Benign
0.83
PhyloP100
-0.58
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4126690; hg19: chr1-181484543; API